Advertisement

Topics

Merck's Keytruda gets FDA nod for cervical cancer treatment

06:27 EDT 13 Jun 2018 | SmartBrief

The FDA granted accelerated approval to Merck's Keytruda, or pembrolizumab, as a treatment for patients with recurrent or met -More

Original Article: Merck's Keytruda gets FDA nod for cervical cancer treatment

NEXT ARTICLE

More From BioPortfolio on "Merck's Keytruda gets FDA nod for cervical cancer treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...